Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead goes long-acting in HIV
EP Vantage
Fri, 12/23/22 - 10:35 am
Gilead Sciences
lenacapavir
HIV
FDA
Kite swoops in to buy Carl June-founded Tmunity, gaining key to Penn's CAR-T research apparatus
Fierce Biotech
Tue, 12/20/22 - 11:17 am
Kite Pharma
Gilead Sciences
M&A
CAR-T
Tmunity
Carl June
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
clinical trials
Acadia Pharmaceuticals
Argenx
Arrowhead Pharmaceuticals
Biomarin
BioNTech
Daiichi Sankyo
Day One
EQRx
Fate Therapeutics
FibroGen
Gilead Sciences
Idorsia
Immunogen
Intellia Therapeutics
Karuna Therapeutics
Moderna Therapeutics
Regeneron
Roche
Travere Therapeutics
Vaxcyte
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Gilead Sciences
Gilead lands new cell therapy for Kite in $225M Arcellx deal
Fierce Biotech
Fri, 12/9/22 - 10:37 am
Gilead Sciences
Kite Pharma
Arcellx
clinical trials
Multiple Myeloma
cell therapy
JNJ
Legend Biotech
Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences
NASDAQ.com
Thu, 12/8/22 - 10:03 am
Daiichi Sankyo
Gilead Sciences
Yescarta
Japan
Federal claims court rules in favor of Gilead in CDC Truvada patent case
Endpoints
Thu, 12/1/22 - 07:08 pm
Gilead Sciences
Truvada
PrEP
HIV
CDC
patents
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
FDA
Mirati Therapeutics
Gilead Sciences
Coherus Biosciences
Roche
Biogen
TG Therapeutics
Ipsen
Novartis
BeiGene
Cytokinetics
Gilead, Arcus hope to ease TIGIT anxieties with latest trial data tease
Fierce Biotech
Mon, 11/28/22 - 07:37 pm
Gilead Sciences
Arcus Biosciences
clinical trials
domvanalimab
zimberelimab
non-small cell lung cancer
Gilead dodges Supreme Court review—and a $1.2B fine—in CAR-T patent feud with Bristol Myers
Fierce Pharma
Mon, 11/7/22 - 05:48 pm
Gilead Sciences
Kite Pharma
Bristol Myers Squibb
cell therapy
legal
CAR-T
Yescarta
Gilead, Arcus slim phase 3 TIGIT trial to take on king Keytruda
Fierce Biotech
Thu, 11/3/22 - 11:10 am
Gilead Sciences
ARCUS
clinical trials
Merck
Keytruda
domvanalimab
zimberelimab
non-small cell lung cancer
Gilead's Hopes for HDV Approval Delayed after CRL
BioSpace
Sun, 10/30/22 - 04:15 pm
Gilead Sciences
hepatitis D
FDA
buleviritide
Gilead, working to improve cancer cell therapy, partners with California startup
BioPharma Dive
Thu, 10/20/22 - 11:28 pm
Gilead Sciences
Refuge Biotechnologies
CAR-T
Gilead touts Veklury resilience against mutated coronavirus, plots phase 3 for new COVID oral antiviral
Fierce Pharma
Wed, 10/19/22 - 11:03 am
Gilead Sciences
COVID-19
clinical trials
Veklury
Gilead, MacroGenics Unite Against Hematologic Cancers in $1.7B Biobuck Deal
BioSpace
Mon, 10/17/22 - 10:26 am
Gilead Sciences
Macrogenics
hematological cancers
drug development
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
FDA
Biogen
Eisai
Alzheimer's disease
Gilead Sciences
HIV
Mirati Therapeutics
lung cancer
lecanemab
lenacapavir
adagrasib
After a rocky few months, Gilead's Trodelvy keeps recent winning streak rolling with priority review
Fierce Pharma
Tue, 10/11/22 - 04:08 pm
Gilead Sciences
breast cancer
Trodelvy
ESMO
FDA
priority review
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
M&A
Pfizer
Global Blood Therapeutics
Amgen
ChemoCentryx
Novo Nordisk
Forma
Alcon
Aerie Pharmaceuticals
Gilead Sciences
MiroBio
Gilead targets 'large-scale' HIV drugs counterfeiting scheme as judge orders asset freeze
Fierce Pharma
Thu, 09/29/22 - 07:40 pm
Gilead Sciences
HIV
drug counterfeiting
legal
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »